FI952324A - Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet - Google Patents
Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet Download PDFInfo
- Publication number
- FI952324A FI952324A FI952324A FI952324A FI952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A FI 952324 A FI952324 A FI 952324A
- Authority
- FI
- Finland
- Prior art keywords
- carbomate
- heterocyclic
- drugs
- preparation
- heterocyclic carbomate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4333761A DE4333761A1 (de) | 1993-10-04 | 1993-10-04 | Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel |
PCT/EP1994/003280 WO1995009842A1 (en) | 1993-10-04 | 1994-10-04 | Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
Publications (2)
Publication Number | Publication Date |
---|---|
FI952324A true FI952324A (fi) | 1995-05-12 |
FI952324A0 FI952324A0 (fi) | 1995-05-12 |
Family
ID=6499349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI952324A FI952324A0 (fi) | 1993-10-04 | 1995-05-12 | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet |
Country Status (9)
Country | Link |
---|---|
US (1) | US5679677A (fi) |
EP (1) | EP0649839A1 (fi) |
JP (1) | JPH08504216A (fi) |
AU (1) | AU684314B2 (fi) |
CA (1) | CA2148361A1 (fi) |
DE (2) | DE4333761A1 (fi) |
FI (1) | FI952324A0 (fi) |
NO (1) | NO952205L (fi) |
WO (1) | WO1995009842A1 (fi) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7261742B2 (en) * | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
US7407922B2 (en) * | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
KR101419075B1 (ko) * | 2006-08-08 | 2014-07-11 | 아스카 세이야쿠 가부시키가이샤 | 퀴나졸린 유도체 |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
CN101641013B (zh) | 2007-01-22 | 2014-07-30 | Gtx公司 | 核受体结合剂 |
US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
ES2576643T3 (es) | 2007-03-09 | 2016-07-08 | Second Genome, Inc. | Compuestos de bicicloheteroarilo como moduladores de P2X7 y usos de los mismos |
JP5848761B2 (ja) * | 2010-06-24 | 2016-01-27 | アルカーメス ファーマ アイルランド リミテッド | Nh酸性化合物のプロドラッグ:エステル、カルボネート、カルバメートおよびホスホネートの誘導体 |
WO2012058211A2 (en) * | 2010-10-29 | 2012-05-03 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
JP6466924B2 (ja) | 2013-10-04 | 2019-02-06 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 複素環式化合物及びその使用 |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9775844B2 (en) | 2014-03-19 | 2017-10-03 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
CA2998469A1 (en) | 2015-09-14 | 2017-03-23 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE36226B1 (en) * | 1935-11-11 | 1976-09-15 | Shimamoto Takio | Phthalazone derivatives |
FR1460552A (fr) * | 1965-04-22 | 1966-03-04 | Agripat Sa | Additifs à des nourritures pour animaux |
NL6702189A (fi) * | 1967-02-14 | 1968-08-15 | ||
DE1807685A1 (de) * | 1968-11-08 | 1970-08-06 | Chinoin Gyogyszer Es Vegyeszet | Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben |
CH540266A (de) * | 1968-12-04 | 1973-08-15 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Chinazolon-Derivaten |
JPS5418270B2 (fi) * | 1971-12-06 | 1979-07-06 | ||
AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
GB2127805A (en) * | 1982-09-13 | 1984-04-18 | Showa Denko Kk | Phthalazones |
JPS5976069A (ja) * | 1982-10-25 | 1984-04-28 | Showa Denko Kk | フタラゾン誘導体 |
US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
-
1993
- 1993-10-04 DE DE4333761A patent/DE4333761A1/de not_active Withdrawn
- 1993-10-04 DE DE4345266A patent/DE4345266C2/de not_active Expired - Fee Related
-
1994
- 1994-10-04 CA CA002148361A patent/CA2148361A1/en not_active Abandoned
- 1994-10-04 AU AU77845/94A patent/AU684314B2/en not_active Ceased
- 1994-10-04 WO PCT/EP1994/003280 patent/WO1995009842A1/en active Application Filing
- 1994-10-04 EP EP94115598A patent/EP0649839A1/en not_active Withdrawn
- 1994-10-04 US US08/446,867 patent/US5679677A/en not_active Expired - Fee Related
- 1994-10-04 JP JP7510611A patent/JPH08504216A/ja active Pending
-
1995
- 1995-05-12 FI FI952324A patent/FI952324A0/fi unknown
- 1995-06-02 NO NO952205A patent/NO952205L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU684314B2 (en) | 1997-12-11 |
CA2148361A1 (en) | 1995-04-13 |
DE4345266A1 (de) | 1995-06-29 |
US5679677A (en) | 1997-10-21 |
DE4345266C2 (de) | 1996-12-19 |
NO952205D0 (no) | 1995-06-02 |
AU7784594A (en) | 1995-05-01 |
FI952324A0 (fi) | 1995-05-12 |
DE4333761A1 (de) | 1995-04-06 |
WO1995009842A1 (en) | 1995-04-13 |
JPH08504216A (ja) | 1996-05-07 |
EP0649839A1 (en) | 1995-04-26 |
NO952205L (no) | 1995-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941137A0 (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
FI953981A (fi) | 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi | |
FI893542A0 (fi) | Entsyymielektrodit ja menetelmä niiden valmistamiseksi | |
FI953479A (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
FI952324A (fi) | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet | |
IS3720A7 (is) | Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun | |
FI953898A0 (fi) | Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita | |
BR9101250A (pt) | Metodo e aparelhagem de medicao de distancia | |
FI962344A0 (fi) | Järjestelmä ja menetelmä selluloosan sisäänruiskuttamiseksi | |
FI941777A0 (fi) | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi | |
FI935485A0 (fi) | PEG-hydrazon- och PEG-oximbindningen bildande reagens och proteinderivat daerav | |
FI954718A0 (fi) | Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi | |
FI962445A (fi) | Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi | |
FI95914C (fi) | Polypeptidijohdannaisia ja menetelmä niiden valmistamiseksi | |
FI944906A (fi) | Uudet sykliset aminohapot ja niiden johdannaiset | |
FI964310A0 (fi) | Imidatsolijohdannainen ja menetelmä sen valmistamiseksi | |
FI941914A0 (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö | |
FI944842A0 (fi) | Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi | |
FI961977A0 (fi) | N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö | |
FI940403A0 (fi) | Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi | |
ATE202351T1 (de) | Pyridinderivate und sie enthaltende pharmazeutische zubereitungen | |
FI964148A (fi) | Julkisivumateriaali ja menetelmä sen valmistamiseksi | |
BR9106582A (pt) | Derivados de tetrazol e medicamentos | |
NZ239186A (en) | Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical | |
FI930378A (fi) | Fosfenoxidavslutade allen-en-yn dna-spjaelkande, antitumoer och antibiotika molekyler |